Consensus

As a core objective of the AAPPO is to advance academic exchange and knowledge in ophthalmology across the Asia-Pacific region and beyond, the Council resolved during the 2025 Annual General Meeting to prioritize the development of consensus and guidelines papers for important and blinding eye diseases. These consensus papers are critical for setting new standards in patient care, bridging gaps in clinical decision-making, and shaping the future of ophthalmology. By providing evidence-based recommendations, they will enhance clinical practice, improve patient outcomes, and promote consistency across diverse healthcare settings.

While many consensus papers exist, there is no universally accepted definition or criteria on how to reach consensus for a statement. Taking reference form the consensus paper on PCV by APVRS (Asia-Pacific Vitreo-Retina Society), consensus was defined as at least 75% of responses indicating agreement (i.e. strongly agree or agree) with the statement, a definition proposed by one of the authors (Dennis Lam) of the paper and endorsed by all the APVRS PCV panel experts1. This establishes a clear framework for defining consensus. Fan et al commended highly on this new definition. This new approach may become a benchmark on how to reach agreement on a consensus statement for consensus and guidelines papers in the future2. We will adopt this new approach for our consensus projects.

The AAPPO shall collaborate with APVRS, AMPS (Asia-Pacific Society of Myopia), APSOII (Asia-Pacific Society of Ocular Inflammation and Infection), APGS (Asia-Pacific Glaucoma Society), and APOIS (Asia-Pacific Ocular Imaging Society) to address controversies, foster debate, and establish 10 – 25 consensus papers and guidelines in 2025.

As of July 2025, 12 consensus documents have been ready and 6 papers have been accepted for publication by internationally reputable journals, marking significant progress toward achieving the goal for 2025.

Prof. Charles McGhee, AAPPO President

References:
1. Ruamviboonsuk P, Ng DSC, Chaikitmongkol V, et al Consensus and Guidelines on Diagnosis and Management of Polypoidal Choroidal Vasculopathy (PCV) from the Asia-Pacific Vitreo-retina Society (APVRS). Asia Pac J Ophthalmol. 2025;14:100144.
2. Fan X, Tham CC, Leung CKS, et al. Definition for consensus statement much needed. Asia Pac J Ophthalmol. 2025;14:100141.

Consensus Projects Update:

AAAPO (Academy of Asia-Pacific Professors of Ophthalmology)
APMS (Asia-Pacific Myopia Society); APOIS (Asia-Pacific Ocular imaging Society)
APOIS (Asia-Pacific Ocular imaging Society)
APSOII (Asia-Pacific Ocular Inflammation and Infection Society)
APVRS (Asia-Pacific Vitreo-retina Society)

No. Eye Disease Collaborating Societies Key Coordinator Status
1 Posterior Chamber Phakic Intraocular Lens (ICL) AAPPO, APMS Zhou Xingtao (China)
2 Macular Hole Surgery AAPPO, APVRS Dennis Lam (Hong Kong)
3 Acute Primary Angle Closure Attack (APACA) AAPPO, APGS Clement Tham (Hong Kong)
4 Cataract Surgery AAPPO Jorge Alio (Spain)
5 Intraocular Foreign Bodies (IOFB) AAPPO, APVRS Dennis Lam (Hong Kong)
6 Small Incision Lenticule Extraction (SMILE) AAPPO, APMS Dennis Lam (Hong Kong)
7 Diabetic Macular Edema (DME) AAPPO, APVRS, APOIS Tien Wong (China)
  • Consensus ready
  • Under journal review
8 Fungal Endophthalmitis AAPPO, APVRS, APSOII TP Das (India)
  • Consensus ready
  • Under journal review
9 Endophthalmitis After Cataract AAPPO, APVRS, APSOII Namrata Sharma (India)
  • Consensus ready
  • Under journal review
10 Neovascular Age-related Macular Degeneration (nAMD) AAPPO, APVRS Tim Lai (Hong Kong)
  • Consensus ready
  • Under journal review
11 Coat’s disease AAPPO, APVRS Mahesh Shanmugam (India)
  • In preparation
12 Ocular Behcet’s Disease AAPPO, APVRS, APSOII Mary Ho (Hong Kong)
  • Consensus ready
  • Under journal review
13 Proliferative Diabetic Retinopathy (PDR) AAPPO, APVRS Dennis Lam (Hong Kong)
  • Consensus ready
  • Under journal review
14 Multifocal Intraocular Lenses AAPPO Jorge Alio (Spain)
  • In preparation
15 Central Serous chorioretinopathy (CSC) AAPPO, APVRS Camil Boom (Netherland)
  • In preparation
16 Pachydrusen AAPPO, APVRS Marisko Sasaki (Japan)
  • In preparation
17 Keratoconus AAPPO
  • In preparation
18 Microbial Keratitis AAPPO, APSOII Namrata Sharma (India)
  • In preparation
19 Cytomegalovirus (CMV) Retinitis AAPPO, APSOII, APVRS Yong Tao (China)
  • In preparation
20 Ocular Toxoplasmosis AAPPO, APSOII, APVRS Rupesh Agrawal (Singapore)
  • In preparation
21 Rhegmatogenous Retinal Detachment AAPPO, APVRS Paisan Ruamviboonsuk (Thailand)
  • In preparation